Ship Of Theseus LLC
Eagleville, PA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1271 Quarry Hall Rd, Eagleville, PA 19403, USA
- Website
- ship-of-theseus.com
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| An inside out approach that reprograms wound tissue to accelerate chronic wound healing in aging populations | National Institute on Drug Abuse (NIH) | $365,689 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Asymmetrex, LLC | Boston, MA | — |
| Ossium Health, Inc. | Indianapolis, IN | 325414 Biological Product (except Diagnostic) Manufacturing |
| Endomimetics, Inc. | Birmingham, AL | — |
| Creative Biotherapeutics LLC | Gurnee, IL | — |
| Aleutian Therapeutics, Inc. | Los Angeles, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Ship Of Theseus LLC is a for-profit limited liability company registered in SAM.gov since February 15, 2018, located in Eagleville, Pennsylvania. The company appears to be a biotechnology research and development firm focused on developing innovative medical technologies, with a particular emphasis on stem cell research and therapeutic interventions for medical conditions related to aging, cancer, and hematological disorders. Its core technological approach centers on developing advanced biological interventions, specifically around manipulating and expanding hematopoietic stem cells to improve medical treatment outcomes.
The company has received one federal contract award from the National Institutes of Health National Institute on Aging, specifically a $365,688.80 firm fixed price contract under the Small Business Innovation Research program. This contract was awarded to develop an innovative approach for reprogramming wound tissue to accelerate chronic wound healing in aging populations. The contract was a total small business set-aside and was completed by November 2023, demonstrating the company's capability to execute targeted medical research projects for federal agencies.
Ship Of Theseus LLC has been significantly more active in federal grant awards, receiving multiple project grants from prestigious federal agencies like the National Cancer Institute and the National Heart, Lung and Blood Institute. These grants, totaling approximately $1.3 million, focus on preclinical development of advanced stem cell expansion technologies, particularly a patented mutant of the nuclear transcription factor HOXB4 (HOXB4(M)). The research aims to improve hematopoietic stem cell transplant procedures by developing a biologic that can safely increase stem cell expansion in vivo, potentially reducing neutropenia recovery time after chemotherapy and bone marrow transplants. The company has collaborated with research institutions like the University of Pennsylvania Center for Cellular Immunotherapies, indicating a strong academic and translational research orientation in their grant-funded work.
Quick answers
Is Ship Of Theseus LLC registered in SAM.gov?
Yes. Ship Of Theseus LLC's SAM.gov registration is active through January 25, 2027.
What is Ship Of Theseus LLC's CAGE code?
Ship Of Theseus LLC's CAGE code is 81Y67, and its Unique Entity ID (UEI) is NBZMY6CX12K6.
What is Ship Of Theseus LLC's most recent federal award?
Ship Of Theseus LLC's most recent federal grant award is Preclinical development of a tandem cart / HSC transplantation platform for hematologic malignancies (R41CA310331), from National Cancer Institute (NIH), on September 10, 2025.
On GovTribe
See Ship Of Theseus LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors